Upcoming Webinar
Advancing Public Health with Wearables: Strategic Development of IoMT Biosensing Lifestyle Devicesﾂfor the AdvaMed community
On窶ｯSeptember 15th at noon Eastern join us as窶ｯMIDI and Valencell present窶ｯﾂ窶廣dvancing Public Health with Wearables: Strategic Development of IoMT Biosensing Lifestyle Devices窶敖for the entire AdvaMed community.ﾂPresented by窶ｯChristopher Montalbano, CEO, MIDI Medical Device Development Corp., and Ryan Kraudel, Vice President, Marketing, Valencell, Inc., this窶ｯwebinar will examine the way in which wearables advance the public health when a strategic device development approach is utilized to integrate and harmonize: Lifestyle, IoMT, Biosensing, and Physiological Sensing.
In the webinar, MIDI & Valencell will help you:窶ｯ
- Understand how wearable IoMT devices utilizing Bio-Sensors and Physiological Sensors translate into enhanced healthcare and wellness lifestyles.
- Learn how to optimize the selection of sensor (or sensor cluster) through a proven 4-Step approach of User Experience Monitoring, Body Assessments, Key Body Metric Capture, and Sensor Selection.
- Learn the 3-Step Innovation Roadmap邃｢ for optimized wearable device development including Discovery Research邃｢, MVP R&D, and AGILE Commercialization under ISO-13485.
- Review of Case Studies that demonstrate implementation of these innovation principles yielding advanced wearable IoMT healthcare sensing devices.
MIDI窶冱 Interactive Roundtable Session performed for AdvaMed窶冱 Accel Community
MIDI is providing a Roundtable Session for AvaMed’s Accel Community with a focus on; Advanced Medical Device Commercialization.
This session will provide the opportunity to learn more about:
- MIDI窶冱 DevelopmentDNATM stage-gate development commercialization process.
- Integration of an FDA Overlay within DevelopmentDNATM
- How to infuse innovation and competitive differentiation into your device design
